ABSTRACT

The process of drug discovery has benefited in the past decade by the advent and rise of high-throughput screening, an early and vital step of screening small molecule libraries primarily through biochemical and cell-based assays. This entry first discusses the history of HTS in drug discovery then moves to a more detailed examination of HTS in the pharmaceutical industry.